By 2030, the volume of production of veterinary preparations in the Russian Federation will exceed 82 billion rubles

The largest share - 70% - belongs to products for farm animals, poultry, and 30% - products for companion animals. Compared with a stable figure of 54-56 billion rubles. for the period 2019-2021 This is a rapidly growing market. According to the forecasts of the association, by 2030 the volume of production of veterinary preparations in the Russian Federation will grow to 82.5 billion rubles.

The main categories of animal medicines used are:

● immunobiological (vaccines and sera) – 45% of the market or 28.8 billion rubles.

● chemical and pharmaceutical (other drugs) – 55% or RUB 34.9 billion.

Russian veterinary companies that are members of the NVA, the Vetbioprom association, and the FGBI ARRIAH account for 88% of domestic production.

There is a positive trend in the growth of the share of Russian products in the market of veterinary drugs: from 2018 to 2022. it increased from 30 to 43%. A significant contribution to the increase was made by enterprises belonging to the National Veterinary Association, which increased the volume of production over the specified period by 2.4 times.

At the end of 2022, Russian manufacturers occupied more than half of the market for chemical and pharmaceutical preparations. The category of products for hygiene and disinfection is the most import-independent group: only 9% are accounted for by foreign manufacturers, and, accordingly, 91% of products are produced by Russian companies.

There are enough antibacterial agents produced in the Russian Federation - 52%, competition is felt between Russian antibiotics. In addition, large manufacturing enterprises have sufficient capacity to cover the needs for antibacterial drugs in the event of a sharp increase in demand in the next year and a half.

A certain dependence on imports remains in a number of areas:

antiparasitic drugs - only 16% is produced in RUSSIA,

coccidiostats - 21% of domestic drugs,

hormones - 23%,

immunobiological preparations - 33%.

However, a number of enterprises are implementing programs to commission new capacities and expand the range in these categories, as well as in the segment of sterile injectables and suspensions, which also have growth potential.

The goal of this year is to reduce the share of imports in chemical pharmaceuticals and immunobiology. And the potential of Russian manufacturers, based on market trends, is significant: since 2018, the production of vaccines has increased by 2.3 times, hormones - by 2 times, and all categories of veterinary products - by 70%.

Among domestic vaccines, almost the entire line is presented to combat the main infectious diseases of animals and birds.

In the segment of veterinary drugs for farm animals and poultry, the market shares of veterinary drugs in 2022 are distributed as follows: 61% (27.2 billion rubles) - imports, 39% (17.5 billion rubles) - Russian production. Of these, immunobiological drugs - 41% (18.4 billion rubles), chemical-pharmaceutical - 59% (26.3 billion rubles).

Domestic production of vaccines for farm animals and poultry is 19% or equal to 3.3 billion rubles.

State support provided to manufacturers of veterinary drugs in the field of simplified registration of medicines makes it possible to introduce new technically complex and capital-intensive programs. Such projects will allow covering the needs of the Russian market for antiparasitic drugs, coccidiostats and hormones within two years.

In 2022, thanks to simplified registration, 30 new drugs were launched, which is twice as many as in 2021. In 2023, 60 products are planned for launch.

The separation of the veterinary industry into a separate area of ​​economic activity in March of this year allows us to hope for further support for domestic producers: maintaining simplified registration, accelerating validation procedures, developing targeted programs, subsidizing and concessional lending, as well as obtaining the status of backbone companies for companies that account for 88% of Russian production. enterprises.

Large domestic manufacturers of veterinary drugs, having their own developed scientific and technical base, are already quite capable of competing with the world's leading pharmaceutical companies, increasing production volumes, covering import needs and making significant EXPORT deliveries. Moreover, at the forefront is ensuring food independence, the biological security of the country and the availability of food for the population.